HolmesAI to Bring its CLholme platform into Southeast Asia: Diagnosing and Predicting Heart Disease…
HolmesAI, with the CLholmes platform that diagnoses 21 types of cardiac arrhythmias, plans to participate in CES 2025.
HolmesAI CEO Dong Seok Lim…